BDF Gestion
NBIX icon

BDF Gestion’s Neurocrine Biosciences NBIX Stock Holding History

BDF Gestion’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.49M Sell
10,523
-1,335
-11% -$215K 0.2% 117
2026
Q2 		$3M Buy
+11,858
New +$1.76M 0.4% 63

Other funds holding NBIX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $340M AUM 228.33% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
PensionDanmark
PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

BDF Gestion's NBIX Position: Q3 2026 in Review

BDF Gestion reduced its Neurocrine Biosciences (NBIX) stake by 11% in Q3 2026, selling an estimated $215K and leaving 10,523 shares worth $1.49M. The position accounts for 0.2% of the portfolio, ranked #117.

BDF Gestion first reported a position in NBIX in Q2 2026 and has held it in 2 quarters since. The position peaked at $3M in Q2 2026. 91 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • BDF Gestion held 10,523 shares of Neurocrine Biosciences worth $1.49M as of Q3 2026.
  • BDF Gestion sold 1,335 Neurocrine Biosciences shares in Q3 2026, an estimated $215K.
  • Neurocrine Biosciences made up 0.2% of BDF Gestion's portfolio in Q3 2026, its #117 holding.
  • BDF Gestion first reported a position in Neurocrine Biosciences in Q2 2026 and has held it in 2 quarters since.
  • BDF Gestion's Neurocrine Biosciences position peaked at $3M in Q2 2026.
  • 91 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on BDF Gestion's 13F filing for Q3 2026, filed 19 Oct 2026.